Klow Peptide Dosing Guide: Optimal Protocols

Overview

The Klow blend is a popular three-peptide combination used in research and clinician-guided protocols for tissue repair, recovery, and maintenance. It combines BPC-157, TB-500, and GHK-Cu into a single vial, which means one injection delivers all three compounds at once. This guide explains typical Klow peptide dosing patterns, how the blend compares to pinning each compound separately, and what a practical dosing chart looks like. You can use our Klow blend dosage calculator → to plan protocol schedules and check reconstitution math. Use this as an educational resource, not a personal prescription — any peptide protocol should be discussed with a licensed healthcare provider.

What is the Klow blend?

The Klow blend is a pre-mixed combination of three well-known peptides, each contributing a different mechanism to the tissue-repair process:

• BPC-157 — supports tendon and ligament repair, gut health, and anti-inflammatory pathways
• TB-500 — promotes actin binding, tissue flexibility, muscle fiber repair, and anti-fibrotic activity
• GHK-Cu — stimulates collagen synthesis, wound healing, and gene expression related to tissue remodeling

Together, these three compounds cover tissue repair from multiple angles, which is why the blend has become popular for musculoskeletal injuries. To calculate your protocol dosing, see our Klow blend dosage calculator →, surgical recovery, joint pain, and general maintenance protocols.

Who uses the Klow blend?

The Klow blend is commonly discussed in the context of:

• Recovery from tendon, ligament, or muscle injuries
• Joint pain associated with osteoarthritis, tendinitis, or bursitis
• Post-surgical recovery acceleration
• General tissue integrity and collagen support
• Athletic recovery during heavy training phases

It is often used as a standalone protocol for 8 to 12 weeks during an acute recovery phase, then cycled off or reduced to a maintenance frequency.

Klow peptide dosing chart

The chart below summarizes common clinician-guided Klow dosing patterns. The right protocol depends on the individual, product concentration, health history, and provider plan. This chart is educational only — not a self-treatment prescription. If you want to organize a protocol schedule or check reconstitution math, use our Klow blend dosage calculator → — but only as a conversation tool, not a self-treatment plan.

Phase	Frequency	Duration	Route	Use Case
Acute loading	4-5x per week (or daily)	8-12 weeks	SubQ injection, lower abdomen or near target tissue	Active injury recovery, post-surgical repair
Maintenance	2-3x per week	Ongoing	SubQ injection, lower abdomen	Collagen support, anti-inflammatory baseline, general wellness
Reduced dose (edema management)	2-3x per week at 50% dose	2 weeks reassessment	SubQ injection	If water retention occurs, reduce and reassess

Reconstitution and administration

Standard reconstitution for the Klow blend uses bacteriostatic water at 2 mL per vial. The injection is typically administered subcutaneously in the lower abdomen or near the target tissue for localized effect.

Key reconstitution notes:

• Use bacteriostatic water (BAC water) for reconstitution
• Standard dilution: 2 mL per vial
• After reconstitution, refrigerate and use within 4 to 6 weeks. For exact reconstitution math, use our Klow blend dosage calculator →
• Lyophilized (unreconstituted) vials are stable at room temperature during shipping

Klow vs separate peptide dosing

The Klow blend is convenient, but there are situations where separate vials outperform the blend. Understanding both approaches helps clarify which may be appropriate for a given research goal.

Approach	BPC-157 Dose	TB-500 Dose	GHK-Cu Dose	Frequency
Klow blend (combined vial)	Per blend ratio	Per blend ratio	Per blend ratio	4-5x/week
Separate vials (equivalent)	250-500 mcg	2.5 mg	1-2 mg	BPC/GHK daily, TB-500 2x/week

When using separate vials, BPC-157 and GHK-Cu can be drawn into the same syringe since they are compatible. TB-500 is typically kept in a separate syringe because it is reconstituted at a higher volume.

When separate vials may be preferable

1. Targeting a specific injury — BPC-157 for tendinitis may need a higher dose than what the blend provides per injection. Localized injection near the target tissue is more practical with individual vials.

2. Managing water retention — If the blend causes edema (primarily a TB-500 effect), separate vials allow you to reduce or pause TB-500 while maintaining BPC-157 and GHK-Cu.

3. Tracking compound-specific effects — When combined with GLP-1 agonists or other compounds, pinning separately makes it easier to attribute effects to each peptide.

4. Optimizing per-compound dosing — GHK-Cu for collagen support may benefit from 2 mg per day, while BPC-157 for gut health may only need 250 mcg. A fixed-ratio blend does not allow that adjustment.

Side effects and water retention

The most commonly reported side effect with the Klow blend is pitting edema — water retention that appears as mild swelling, particularly in the thighs, calves, or hands. This is primarily a TB-500 dose effect and is not considered dangerous.

What to do if edema occurs:

• Reduce Klow dose by 50% and reassess after 2 weeks
• If on daily frequency, drop to 3 times per week
• If edema persists, switch to separate vials and pause TB-500
• Stay well-hydrated, which can help flush retained fluid

Most people find edema resolves once the body adapts within 2 to 4 weeks, or by reducing injection frequency.

Klow vs GLOW: what is the difference?

GLOW is a closely related variant with a different formulation ratio — typically containing more GHK-Cu relative to BPC-157, leaning slightly more toward collagen, skin, and anti-aging applications.

• Klow — repair and recovery focus (higher BPC-157 and TB-500 emphasis)
• GLOW — collagen and longevity focus (higher GHK-Cu emphasis)

In practice, both are used interchangeably for most recovery applications. The difference is subtle and vendor-dependent — always check the actual compound ratios on your specific product label.

Timing and expectations

Most people report improvements in joint comfort and mobility within 2 to 4 weeks of consistent use. Deeper tissue repair (tendon, ligament, disc) typically takes 6 to 8 weeks. GHK-Cu collagen effects on skin and hair often take 4 to 8 weeks to become visible.

The full loading phase runs 8 to 12 weeks, after which many protocols transition to maintenance at 2 to 3 times per week or cycle off entirely for a rest period.

Related Peptides

Frequently Asked Questions

Related Guides